Novavax COVID-19 Vaccine Adjuvanted from Mexico
Novavax protein-based COVID-19 vaccine with Matrix-M adjuvant, in pre-filled syringes for measured retail doses. Classified as immunological product HTS 3002.15.00.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Saponin adjuvant certificates; hypersensitivity warnings
• 2-8°C storage; 30-day room temp stability post-thaw
• Bulk protein antigen as 3002.30 without adjuvant